Home » Topics » BioWorld Science

BioWorld Science
RSS

Emergex advances early development of vaccine candidate against F. tularensis

Dec. 12, 2019

Transgene opens enrollment in phase I study of TG-4050 for ovarian cancer

Dec. 12, 2019

Xintela's function-blocking antibody suppresses growth of glioblastoma tumors in preclinical model

Dec. 12, 2019

Canadian researchers synthesize new androgen receptor antagonists

Dec. 12, 2019

Helix begins phase Ib/II study of L-DOS47 in previously treated pancreatic cancer

Dec. 12, 2019

Roche and Genentech identify SCN9A blockers

Dec. 12, 2019

3M Pharmaceuticals presents cytokine-releasing compounds for infections

Dec. 12, 2019

Beijing Scitech-Mq Pharmaceuticals patents EGFR and/or ALK inhibitors

Dec. 12, 2019

BAR Pharmaceuticals describes new NR1H4 antagonists

Dec. 12, 2019

Transgene and BioInvent report preclinical data on BT-001 for solid tumors

Dec. 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...